Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.385
+0.080 (3.47%)
At close: May 28, 2026, 4:00 PM EDT
2.410
+0.025 (1.05%)
After-hours: May 28, 2026, 5:32 PM EDT
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
n/a
Profits / Employee
-$1,381,859
Market Cap
430.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% | 78 | 0 |
| Dec 31, 2024 | 150 | -15 | -9.09% | 140 | 10 |
| Dec 31, 2023 | 165 | -19 | -10.33% | 152 | 13 |
| Dec 31, 2022 | 184 | -4 | -2.13% | 163 | 21 |
| Dec 31, 2021 | 188 | 81 | 75.70% | 170 | 18 |
| Jun 30, 2021 | 121 | - | - | 121 | 0 |
| Mar 31, 2021 | 107 | - | - | 97 | 10 |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Verastem | 102 |
| InflaRx | 65 |
| Lexeo Therapeutics | 59 |
| Zura Bio | 40 |
IPSC News
- 1 day ago - Century Therapeutics initiated with an Outperform at Mizuho - TheFly
- 14 days ago - Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors - GlobeNewsWire
- 15 days ago - Century Therapeutics reports Q1 EPS (11c), consensus (17c) - TheFly
- 15 days ago - Century Therapeutics Reports First Quarter Financial Results and Business Updates - GlobeNewsWire
- 15 days ago - Century Therapeutics Quarterly report: Q1 2026 - Filings
- 15 days ago - Century Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Century Therapeutics Proxy statement: Proxy filing - Filings